Increased anxiety behavior in OLETF rats without cholecystokinin-A receptor

scientific article published on December 2000

Increased anxiety behavior in OLETF rats without cholecystokinin-A receptor is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0361-9230(00)00407-X
P8608Fatcat IDrelease_5plpcklwwncdfkun7tf2svmlua
P698PubMed publication ID11179844

P2093author name stringYamamoto Y
Tsutsumi T
Nagayama H
Akiyoshi J
Isogawa K
Katsuragi S
Kiyota A
P2860cites workOpposite effects mediated by CCKA and CCKB receptors in behavioural and hormonal studies in ratsQ60645802
Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouseQ60645809
Increased adrenocorticotropin responses to acute stress in Otsuka Long-Evans Tokushima Fatty (type 2 diabetic) ratsQ73416439
Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal modelsQ24673072
Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activityQ28334293
Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorderQ34205234
Evidence for an involvement of the brain cholecystokinin B receptor in anxietyQ37395948
Cholecystokinin-dopamine interactionsQ37756133
Cholecystokinin antagonistsQ37774148
Cholecystokinin in anxietyQ41294359
Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat.Q42546497
The effects of cholecystokinin A and B receptor antagonists on exploratory behaviour in the elevated zero-maze in rat.Q42657606
Disrupted cholecystokinin type-A receptor (CCKAR) gene in OLETF ratsQ48044477
Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathwayQ48433757
Cholecystokinin tetrapeptide-induced calcium mobilization in T cells of patients with panic disorder, major depression, or schizophreniaQ48657997
CCK receptor antagonists in animal models of anxiety: comparison between exploration tests, conflict procedures and a model based on defensive behaviours.Q48709502
CCK8 effects on motivational and emotional states of rats involve CCKA receptors of the postero-median part of the nucleus accumbensQ48918859
Decrease in exploratory behavior in naturally occurring cholecystokinin (CCK)-A receptor gene knockout ratsQ48941669
Effect of the selective CCKB receptor antagonist LY288513 on conditioned fear stress in ratsQ49013261
CCK-4-induced calcium mobilization in T cells is enhanced in panic disorder.Q49043236
The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze.Q50116447
Blockade of CCK(B) but not CCK(A) receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: implications for anxiety associated with posttraumatic stress disorder.Q51104863
Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice.Q51115170
The effects of CCKA and CCKB antagonists on activity in the black/white exploration model of anxiety in mice.Q51140032
Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.Q51176483
Evidence for potentiation by CCK antagonists of the effect of cholecystokinin octapeptide in the elevated plus-maze.Q52919417
P433issue6
P921main subjectcholecystokininQ60315441
P304page(s)789-792
P577publication date2000-12-01
P1433published inBrain Research BulletinQ4955784
P1476titleIncreased anxiety behavior in OLETF rats without cholecystokinin-A receptor
P478volume53